Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$32,000.00

The apoptotic caspase proteolytic system

FY 2014-15

Summary
In mammals, there exists a mechanism termed apoptosis, which is a form of cell death, and that is necessary to remove unwanted cells. Apoptosis is employed to kill cells when they are infected, become cancerous, or are simply no longer useful to the body. Failure to do so often leads to diseases. Inside the cell, a family of enzyme named caspases is responsible to stop critical cellular activities during this process. Their activity is at the core of the apoptotic process. Our laboratory is interested in understanding how caspases are activated and regulated in healthy and sick cells. We have developed two projects around this theme. First, because two of these caspases, called caspase-3 and caspase-7, are very similar to each other in their activity towards small synthetic substrates but seem to have a different repertoire of cellular substrates, we are developing a project aiming at finding the molecular determinants that specify this unexpected selectivity. For that we are generating collections of mutant proteins that we characterize. A second project deals with the activation of caspases during apoptosis, which is a dynamic process. It involves relocalization of some of the caspases to different cellular compartments, molecular machines, and a robust transmission of the activation signal from caspase-to-caspase. Therefore, a second project wants to use imaging tools that permit, in living cells, to track caspases in healthy and dying cells. All of our projects will expand our understanding of this fascinating family of enzymes that are key to the life and death processes occurring in our body.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
355388-2010
Name nom
Denault, JeanBernard
Department département
Pharmacologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
5
Nb partie
5
Application title
The apoptotic caspase proteolytic system
Keyword
NSERC
Application summary
In mammals, there exists a mechanism termed apoptosis, which is a form of cell death, and that is necessary to remove unwanted cells. Apoptosis is employed to kill cells when they are infected, become cancerous, or are simply no longer useful to the body. Failure to do so often leads to diseases. Inside the cell, a family of enzyme named caspases is responsible to stop critical cellular activities during this process. Their activity is at the core of the apoptotic process. Our laboratory is interested in understanding how caspases are activated and regulated in healthy and sick cells. We have developed two projects around this theme. First, because two of these caspases, called caspase-3 and caspase-7, are very similar to each other in their activity towards small synthetic substrates but seem to have a different repertoire of cellular substrates, we are developing a project aiming at finding the molecular determinants that specify this unexpected selectivity. For that we are generating collections of mutant proteins that we characterize. A second project deals with the activation of caspases during apoptosis, which is a dynamic process. It involves relocalization of some of the caspases to different cellular compartments, molecular machines, and a robust transmission of the activation signal from caspase-to-caspase. Therefore, a second project wants to use imaging tools that permit, in living cells, to track caspases in healthy and dying cells. All of our projects will expand our understanding of this fascinating family of enzymes that are key to the life and death processes occurring in our body.